Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.8K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.8K
Proteomics01:33

Proteomics

8.6K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
8.6K
Genomics02:02

Genomics

38.1K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
38.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Studying Continuous, Time-varying, and/or Complex Exposures Using Longitudinal Modified Treatment Policies.

Epidemiology (Cambridge, Mass.)·2024
Same author

Linear functional organization of the omic embedding space.

Bioinformatics (Oxford, England)·2021
Same author

Chromatin network markers of leukemia.

Bioinformatics (Oxford, England)·2020
Same author

The role of genes co-amplified with nicastrin in breast invasive carcinoma.

Breast cancer research and treatment·2013
Same author

Efficient estimation of graphlet frequency distributions in protein-protein interaction networks.

Bioinformatics (Oxford, England)·2006
Same author

Modeling interactome: scale-free or geometric?

Bioinformatics (Oxford, England)·2004
Same journal

conMItion: an R package adjusting confounding factors for associations in multi-omics.

Bioinformatics (Oxford, England)·2026
Same journal

SpaMFG: a Spatial Multi-omics Integration Method based on Feature Grouping.

Bioinformatics (Oxford, England)·2026
Same journal

CSCN: Inference of Cell-Specific Causal Networks Using Single-Cell RNA-Seq Data.

Bioinformatics (Oxford, England)·2026
Same journal

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same journal

Enhancing Cross-Context Generalization in Drug Perturbation Prediction with a Multimodal Conditional Diffusion Framework.

Bioinformatics (Oxford, England)·2026
Same journal

Primer Design through Submodular Function Estimation.

Bioinformatics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Oct 25, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.6K

Multi-project and Multi-profile joint Non-negative Matrix Factorization for cancer omic datasets.

D A Salazar1,2, N Pržulj3,4,5, C F Valencia1,2

  • 1Industrial Engineering Department, University of Los Andes, Bogota 111711, Colombia.

Bioinformatics (Oxford, England)
|August 10, 2021
PubMed
Summary
This summary is machine-generated.

A new machine learning method integrates multi-omic data to identify cancer subtypes and predict drug responses. This approach aids in understanding biological processes and discovering genetic signatures for tumor drug sensitivity.

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.8K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.6K

Related Experiment Videos

Last Updated: Oct 25, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.6K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.8K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.6K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Machine learning

Background:

  • Multi-omic data integration is crucial for understanding complex diseases like cancer.
  • Existing methods, such as joint Non-negative Matrix Factorization, enable the exploration of multi-omic datasets to reveal biological insights.
  • Predicting drug sensitivity and patient subtyping are key applications of multi-omic data integration.

Purpose of the Study:

  • To introduce a novel method, Multi-project and Multi-profile joint Non-negative Matrix Factorization (MMJNMf), for integrating diverse multi-omic data.
  • To apply MMJNMf to low-grade glioma data from The Cancer Genome Atlas (TCGA) and Cancer Cell Line Encyclopedia.
  • To demonstrate the method's capability in generating co-clusters, predicting profiles, and relating latent variables.

Main Methods:

  • Developed Multi-project and Multi-profile joint Non-negative Matrix Factorization (MMJNMf).
  • Integrated multi-omic data from experimental and observational sources.
  • Applied the method to low-grade glioma datasets from TCGA and CCLE.

Main Results:

  • Identified gene clusters enriched in cancer-associated biological terms.
  • Discovered similarities between patient and cell line groups based on biological processes.
  • Successfully predicted drug profiles for patients.
  • Identified genetic signatures associated with drug resistance and sensitivity in tumors.

Conclusions:

  • MMJNMf is effective for integrating heterogeneous multi-omic data.
  • The method facilitates the discovery of biologically relevant patterns and predictive biomarkers.
  • This approach enhances our understanding of cancer biology and informs personalized medicine strategies.